Original Research
Published on 18 May 2017
A New Adjuvant MTOM Mediates Mycobacterium tuberculosis Subunit Vaccine to Enhance Th1-Type T Cell Immune Responses and IL-2+ T Cells
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2017.00585
- 6,277 views
- 11 citations


